A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update

Jonathan E Katz; Manuel L Molina; Raul Clavijo; Nachiketh Soodana Prakash; Ranjith Ramasamy

doi:10.1016/j.euf.2018.07.011

A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update

Eur Urol Focus. 2018 Apr;4(3):336-337. doi: 10.1016/j.euf.2018.07.011. Epub 2018 Jul 17.

Authors

Jonathan E Katz¹, Manuel L Molina¹, Raul Clavijo², Nachiketh Soodana Prakash¹, Ranjith Ramasamy³

Affiliations

¹ Department of Urology, University of Miami, Miami, FL, USA.
² Department of Urology, University of California at Davis, Sacramento, CA, USA.
³ Department of Urology, University of Miami, Miami, FL, USA. Electronic address: ramasamy@miami.edu.

PMID: 30025713
DOI: 10.1016/j.euf.2018.07.011

Abstract

Preliminary results from our study provide further evidence that low-intensity extracorporeal shockwave therapy is a safe and effective treatment modality for erectile dysfunction. Our treatment protocol with shockwaves given to men over 2 wk had the most robust effect.

Trial registration: ClinicalTrials.gov NCT03067987.

Publication types

Clinical Trial, Phase II
Randomized Controlled Trial

MeSH terms

Adult
Aged
Aged, 80 and over
Clinical Protocols
Erectile Dysfunction / epidemiology
Erectile Dysfunction / psychology
Erectile Dysfunction / therapy*
Extracorporeal Shockwave Therapy / methods*
Humans
Male
Meta-Analysis as Topic
Middle Aged
Testosterone / blood*
Treatment Outcome

Substances

Testosterone

Associated data

ClinicalTrials.gov/NCT03067987